Qi L - Search Results

1

Structure-activity relationship of cyclic peptide penta-c[Asp-His(6)-DPhe(7)-Arg(8)-Trp(9)-Lys]-NH(2) at the human melanocortin-1 and -4 receptors: His(6) substitution.

Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Rowan K, Yeon M, Franco L, Chu XJ, Chen L, Yagaloff K. Cheung AW, et al. Among authors: qi l. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1307-11. doi: 10.1016/s0960-894x(03)00114-8. Bioorg Med Chem Lett. 2003. PMID: 12657270

2

Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: arginine substitution.

Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Franco L, Yagaloff K, Chen L. Cheung AW, et al. Among authors: qi l. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2407-10. doi: 10.1016/s0960-894x(02)00459-6. Bioorg Med Chem Lett. 2002. PMID: 12161144

3

Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution.

Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Rowan K, Yeon M, Franco L, Chu XJ, Chen L, Yagaloff K. Cheung AW, et al. Among authors: qi l. Bioorg Med Chem Lett. 2003 Jan 6;13(1):133-7. doi: 10.1016/s0960-894x(02)00830-2. Bioorg Med Chem Lett. 2003. PMID: 12467633

4

Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides.

Chu XJ, Bartkovitz D, Danho W, Swistok J, Cheung AW, Kurylko G, Rowan K, Yeon M, Franco L, Qi L, Chen L, Yagaloff K. Chu XJ, et al. Among authors: qi l. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4910-4. doi: 10.1016/j.bmcl.2005.08.012. Bioorg Med Chem Lett. 2005. PMID: 16169218

5

Preparation of human Melanocortin-4 receptor agonist libraries: linear peptides X-Y-DPhe7-Arg8-Trp(or 2-Nal)9-Z-NH2.

Cheung AW, Qi L, Gore V, Chu XJ, Bartkovitz D, Kurylko G, Swistok J, Danho W, Chen L, Yagaloff K. Cheung AW, et al. Among authors: qi l. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5504-8. doi: 10.1016/j.bmcl.2005.08.083. Epub 2005 Oct 3. Bioorg Med Chem Lett. 2005. PMID: 16203134

6

4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: drug-like and non-xanthine based A2B adenosine receptor antagonists.

Cheung AW, Brinkman J, Firooznia F, Flohr A, Grimsby J, Gubler ML, Guertin K, Hamid R, Marcopulos N, Norcross RD, Qi L, Ramsey G, Tan J, Wen Y, Sarabu R. Cheung AW, et al. Among authors: qi l. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4140-6. doi: 10.1016/j.bmcl.2010.05.056. Epub 2010 May 20. Bioorg Med Chem Lett. 2010. PMID: 20541935

7

Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity.

Guertin KR, Setti L, Qi L, Dunsdon RM, Dymock BW, Jones PS, Overton H, Taylor M, Williams G, Sergi JA, Wang K, Peng Y, Renzetti M, Boyce R, Falcioni F, Garippa R, Olivier AR. Guertin KR, et al. Among authors: qi l. Bioorg Med Chem Lett. 2003 Sep 1;13(17):2895-8. doi: 10.1016/s0960-894x(03)00623-1. Bioorg Med Chem Lett. 2003. PMID: 14611852

8

Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

Gillespie P, Pietranico-Cole S, Myers M, Bilotta JA, Conde-Knape K, Fotouhi N, Goodnow RA Jr, Guertin KR, Hamilton MM, Haynes NE, Liu B, Qi L, Ren Y, Scott NR, So SS, Spence C, Taub R, Thakkar K, Tilley JW, Zwingelstein C. Gillespie P, et al. Among authors: qi l. Bioorg Med Chem Lett. 2014 Jun 15;24(12):2707-11. doi: 10.1016/j.bmcl.2014.04.049. Epub 2014 Apr 21. Bioorg Med Chem Lett. 2014. PMID: 24815509

9

Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675).

Haynes NE, Corbett WL, Bizzarro FT, Guertin KR, Hilliard DW, Holland GW, Kester RF, Mahaney PE, Qi L, Spence CL, Tengi J, Dvorozniak MT, Railkar A, Matschinsky FM, Grippo JF, Grimsby J, Sarabu R. Haynes NE, et al. Among authors: qi l. J Med Chem. 2010 May 13;53(9):3618-25. doi: 10.1021/jm100039a. J Med Chem. 2010. PMID: 20405948

10

Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients.

Sarabu R, Bizzarro FT, Corbett WL, Dvorozniak MT, Geng W, Grippo JF, Haynes NE, Hutchings S, Garofalo L, Guertin KR, Hilliard DW, Kabat M, Kester RF, Ka W, Liang Z, Mahaney PE, Marcus L, Matschinsky FM, Moore D, Racha J, Radinov R, Ren Y, Qi L, Pignatello M, Spence CL, Steele T, Tengi J, Grimsby J. Sarabu R, et al. Among authors: qi l. J Med Chem. 2012 Aug 23;55(16):7021-36. doi: 10.1021/jm3008689. Epub 2012 Aug 1. J Med Chem. 2012. PMID: 22809456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,312 results

Search Page